<p>Needham 的分析师 Joshua Reilly 维持了对 Clear Secure 的买入评级，相关的目标价格保持在 45.00 美元不变。</p>
<h3>TipRanks 网络星期一促销</h3>
<ul>
<li>申请享受 TipRanks Premium 60% 的折扣，获取数据支持的洞察和研究工具，让您自信投资。</li>
<li>订阅 TipRanks 的智能投资者精选，通过我们高表现的模型投资组合查看我们的数据，现在也享受 60% 的折扣。</li>
</ul>
<p>Joshua Reilly 给予买入评级的原因是 Clear Secure 最近的成就和未来潜力的多种因素。一个主要原因是 Clear Secure 与 Medicare.Gov 签订的新合同，这对公司来说是一个重要的里程碑。该合作关系旨在增强 Medicare 用户的身份验证和防欺诈能力，最初针对新注册者，最终扩展到整个 Medicare 人群。</p>
<p>此外，该合同被结构为多年的平台费用，具有演变为经常性收入流的潜力。这笔交易不仅在收入和可见性方面是 Clear Secure 平台上最重要的，而且为医疗保健行业和美国联邦政府的进一步机会打开了大门。这些因素共同促成了 Joshua Reilly 的强烈买入评级。</p>
<p>Reilly 关注技术行业，专注于 Veritone、Tyler Technologies 和 Clear Secure 等股票。根据 TipRanks 的数据，Reilly 推荐股票的平均回报为 0.5%，成功率为 41.67%。</p>

<p>Needham 的 Joshua Reilly 对 Clear Secure 维持买入评级，目标价为 45 美元，原因是与 Medicare.Gov 达成的战略合作伙伴关系。该多年度合同增强了 Medicare 用户的身份验证，可能成为一个持续的收入来源，提升 Clear Secure 在医疗和政府部门的可见度和机会。Reilly 的积极展望基于这些因素，促成了强烈的买入评级</p>

<p>Joshua Reilly, an analyst from Needham, maintained the Buy rating on Clear Secure. The associated price target remains the same with $45.00.</p>
<div class="lb-trans"><p>Needham 的分析师 Joshua Reilly 维持了对 Clear Secure 的买入评级，相关的目标价格保持在 45.00 美元不变。</p>
</div><h3>TipRanks Cyber Monday Sale</h3>
<div class="lb-trans"><h3>TipRanks 网络星期一促销</h3>
</div><ul>
<li>Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.</li>
<li>Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio -  now also 60% off</li>
</ul>
<div class="lb-trans"><ul>
<li>申请享受 TipRanks Premium 60% 的折扣，获取数据支持的洞察和研究工具，让您自信投资。</li>
<li>订阅 TipRanks 的智能投资者精选，通过我们高表现的模型投资组合查看我们的数据，现在也享受 60% 的折扣。</li>
</ul>
</div><p>Joshua Reilly has given his Buy rating due to a combination of factors surrounding Clear Secure’s recent achievements and future potential. A major reason for this positive outlook is Clear Secure’s new contract with Medicare.Gov, which is a significant milestone for the company. This partnership is set to enhance identity verification and fraud prevention for Medicare users, initially targeting new enrollees and eventually expanding to the entire Medicare population.</p>
<div class="lb-trans"><p>Joshua Reilly 给予买入评级的原因是 Clear Secure 最近的成就和未来潜力的多种因素。一个主要原因是 Clear Secure 与 Medicare.Gov 签订的新合同，这对公司来说是一个重要的里程碑。该合作关系旨在增强 Medicare 用户的身份验证和防欺诈能力，最初针对新注册者，最终扩展到整个 Medicare 人群。</p>
</div><p>Moreover, the contract is structured as a multi-year platform fee, with the potential to evolve into a recurring revenue stream. This deal is not only the most substantial in terms of revenue and visibility for Clear Secure’s platform but also opens doors for further opportunities within the healthcare sector and with the US Federal government. These factors collectively contribute to the strong Buy rating from Joshua Reilly.</p>
<div class="lb-trans"><p>此外，该合同被结构为多年的平台费用，具有演变为经常性收入流的潜力。这笔交易不仅在收入和可见性方面是 Clear Secure 平台上最重要的，而且为医疗保健行业和美国联邦政府的进一步机会打开了大门。这些因素共同促成了 Joshua Reilly 的强烈买入评级。</p>
</div><p>Reilly covers the Technology sector, focusing on stocks such as Veritone, Tyler Technologies, and Clear Secure. According to TipRanks, Reilly has an average return of 0.5% and a 41.67% success rate on recommended stocks.</p>
<div class="lb-trans"><p>Reilly 关注技术行业，专注于 Veritone、Tyler Technologies 和 Clear Secure 等股票。根据 TipRanks 的数据，Reilly 推荐股票的平均回报为 0.5%，成功率为 41.67%。</p>
</div>

Clear Secure 的战略性医疗保险合作关系推动了强劲的买入评级